Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Dialogues in Clinical Neuroscience
|
August 12, 2008
Bipolar depression: trial-based insights to guide patient care
David E Kemp, David J Muzina, Roger S McIntyre, et al.
Current Psychiatry Reports
|
September 30, 2010
Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms
Jun Chen, Yiru Fang, David E Kemp, et al.
Neuropsychiatric Disease and Treatment
|
March 21, 2009
Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
Prashant Gajwani, David J Muzina, David E Kemp, et al.
The Journal of Clinical Psychiatry
|
April 5, 2011
Clinical utility of early improvement to predict response or remission in acute mania: focus on olanzapine and risperidone
David E Kemp, Ellyn Johnson, Wei V Wang, et al.
Clinical Therapeutics
|
December 20, 2011
Communication of potential benefits and harm to patients and payers in psychiatry: a review and commentary
Renrong Wu, David E Kemp, Martha Sajatovic, et al.
Journal of Clinical Psychopharmacology
|
March 18, 2008
Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review
Keming Gao, David E Kemp, Stephen J Ganocy, et al.
Current Psychiatry Reports
|
November 11, 2006
Acute treatment of mania: an update on new medications
Prashant Gajwani, David E Kemp, David J Muzina, et al.
Journal of Clinical Psychopharmacology
|
September 16, 2010
Metabolic syndrome and its potential effect on treatment response to aripiprazole: a post hoc analysis of the stabilization phase of a long-term, double-blind study in patients with bipolar disorder (CN138-010)
David E Kemp, James M Eudicone, Robert D McQuade, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 20, 2007
Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia
David E Kemp, William S Gilmer, Jenelle Fleck, et al.
The Journal of Clinical Psychiatry
|
January 24, 2008
A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence
Keming Gao, Stephen J Ganocy, Prashant Gajwani, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Dialogues in Clinical Neuroscience
|
August 12, 2008
Bipolar depression: trial-based insights to guide patient care
David E Kemp, David J Muzina, Roger S McIntyre, et al.
Current Psychiatry Reports
|
September 30, 2010
Switching to hypomania and mania: differential neurochemical, neuropsychological, and pharmacologic triggers and their mechanisms
Jun Chen, Yiru Fang, David E Kemp, et al.
Neuropsychiatric Disease and Treatment
|
March 21, 2009
Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
Prashant Gajwani, David J Muzina, David E Kemp, et al.
The Journal of Clinical Psychiatry
|
April 5, 2011
Clinical utility of early improvement to predict response or remission in acute mania: focus on olanzapine and risperidone
David E Kemp, Ellyn Johnson, Wei V Wang, et al.
Clinical Therapeutics
|
December 20, 2011
Communication of potential benefits and harm to patients and payers in psychiatry: a review and commentary
Renrong Wu, David E Kemp, Martha Sajatovic, et al.
Journal of Clinical Psychopharmacology
|
March 18, 2008
Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review
Keming Gao, David E Kemp, Stephen J Ganocy, et al.
Current Psychiatry Reports
|
November 11, 2006
Acute treatment of mania: an update on new medications
Prashant Gajwani, David E Kemp, David J Muzina, et al.
Journal of Clinical Psychopharmacology
|
September 16, 2010
Metabolic syndrome and its potential effect on treatment response to aripiprazole: a post hoc analysis of the stabilization phase of a long-term, double-blind study in patients with bipolar disorder (CN138-010)
David E Kemp, James M Eudicone, Robert D McQuade, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
January 20, 2007
Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia
David E Kemp, William S Gilmer, Jenelle Fleck, et al.
The Journal of Clinical Psychiatry
|
January 24, 2008
A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence
Keming Gao, Stephen J Ganocy, Prashant Gajwani, et al.
Page
of 7